Related Experiment Video
Updated: Jul 25, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Risk sharing as a supplement to imperfect capitation: a tradeoff between selection and efficiency
E M van Barneveld1, L M Lamers, R C van Vliet
1Department of Health Policy and Management, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands. e.van.barneveld@agis-groep.nl
This study examines risk sharing between health insurers and regulators, finding that current methods like outlier or proportional risk sharing may not be optimal. Alternative risk-sharing strategies could better balance insurer selection and efficiency incentives.
Area of Science:
- Health economics
- Insurance market regulation
- Risk management
Background:
- Competitive individual health insurance markets face challenges with imperfect risk adjustment.
- Capitation payments can incentivize adverse selection and reduce efficiency.
- Regulators use risk-sharing mechanisms to mitigate these issues.
Purpose of the Study:
- To analyze the impact of risk sharing on insurer incentives for selection and efficiency.
- To determine the optimal extent of risk sharing in health insurance markets.
- To compare different risk-sharing methods.
Main Methods:
- Theoretical analysis of risk-sharing models.
- Empirical investigation of various risk-sharing forms.
- Evaluation of tradeoffs between selection and efficiency.
Main Results:
- Risk sharing reduces insurer incentives for both selection and efficiency.
- The optimal level of risk sharing depends on regulatory priorities.
- Current outlier or proportional risk sharing may not be the most effective.
Conclusions:
- Alternative risk-sharing mechanisms can offer improved tradeoffs.
- Regulators should consider diverse risk-sharing strategies.
- Optimizing risk sharing is crucial for efficient health insurance markets.
Related Concept Videos
Randomized Experiments
Simple randomization
Simple...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Relative Risk
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Equity Theory

